Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies

被引:79
作者
Crespel, A
Genton, P
Berramdane, M
Coubes, P
Monicard, C
Baldy-Moulinier, M
Gelisse, P
机构
[1] Hop Gui de Chauliac, Epilepsy Unit, F-34295 Montpellier, France
[2] Ctr St Paul H Gastaut, Marseille, France
关键词
D O I
10.1212/01.wnl.0000174517.21383.36
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Five patients with idiopathic generalized epilepsies (IGE) treated with lamotrigine (LTG) experienced exacerbation or de novo appearance of myoclonic jerks (MJ). In three patients, LTG exacerbated MJ in a dose-dependent manner with early aggravation during titration. MJ disappeared when LTG dose was decreased by 25 to 50%. In two patients, LTG exacerbated MJ in a delayed but more severe manner, with myoclonic status that only ceased after LTG withdrawal.
引用
收藏
页码:762 / 764
页数:3
相关论文
共 10 条
[1]  
Biraben A, 2000, NEUROLOGY, V55, P1758
[2]  
Carrazana EJ, 2001, NEUROLOGY, V56, P1424, DOI 10.1212/WNL.56.10.1424-a
[3]   Clinical factors of drug resistance in juvenile myoclonic epilepsy [J].
Gelisse, P ;
Genton, P ;
Thomas, P ;
Rey, M ;
Samuelian, JC ;
Dravet, C .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (02) :240-243
[4]   Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies [J].
Gelisse, P ;
Genton, T ;
Kuate, C ;
Pesenti, A ;
Baldy-Moulinier, M ;
Crespel, A .
EPILEPSIA, 2004, 45 (10) :1282-1286
[5]  
GENTON P, 2000, JUVENILE MYOCLONIC E, P32
[6]   Lamotrigine and seizure aggravation in severe myoclonic epilepsy [J].
Guerrini, R ;
Dravet, C ;
Genton, P ;
Belmonte, A ;
Kaminska, A ;
Dulac, O .
EPILEPSIA, 1998, 39 (05) :508-512
[7]   Myoclonic status epilepticus following high-dosage lamotrigine therapy [J].
Guerrini, R ;
Belmonte, A ;
Parmeggiani, L ;
Perucca, E .
BRAIN & DEVELOPMENT, 1999, 21 (06) :420-424
[8]   Disabling erratic myoclonus during lamotrigine therapy with high serum level -: Report of two cases [J].
Janszky, J ;
Rásonyi, G ;
Halász, P ;
Olajos, S ;
Perényi, J ;
Szûcs, A ;
Debreczeni, J .
CLINICAL NEUROPHARMACOLOGY, 2000, 23 (02) :86-89
[9]  
MARTINEZ JF, 2000, NEUROLOGY S11, V55, pA1758
[10]  
OHTAHARA S, 1997, EPILEPSY COMPREHENSI, V1, P725